Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ANIK

Anika Therapeutics Inc

Mar 13 • 04:00PM ET

14.20

-0.10 -0.70 %

Healthcare • Drug Manufacturers - Specialty & Generic • USA • NASD

Peers: AMGN VRTX REGN BMRN BIIB GILD SRPT INCY NBIX IONS

| Held by: VTI IWM AVUV VXF IWN SCHA DFAS ITOT VTWO DFSV

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.76	Insider Own	3.94%	Shs Outstand	13.89M	Perf Week	0.57%
Market Cap	190.29M	Forward P/E	63.11	EPS next Y	0.23	Insider Trans	0.00%	Shs Float	12.87M	Perf Month	38.54%
Enterprise Value	159.06M	PEG	0.93	EPS next Q	-0.07	Inst Own	92.19%	Short Float	5.69%	Perf Quarter	47.30%
Income	-10.88M	P/S	1.69	EPS this Y	-104.55%	Inst Trans	0.62%	Short Ratio	4.75	Perf Half Y	64.54%
Sales	112.82M	P/B	1.37	EPS next Y	4600.00%	ROA	-4.77%	Short Interest	0.73M	Perf YTD	47.76%
Book/sh	10.33	P/C	3.31	EPS next 5Y	67.83%	ROE	-6.71%	52W High	17.10 -16.96%	Perf Year	-6.64%
Cash/sh	4.29	P/FCF	43.64	EPS past 3/5Y	9.40% 14.76%	ROIC	-6.49%	52W Low	7.87 80.43%	Perf 3Y	-45.49%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-10.28% -2.86%	Gross Margin	56.56%	Volatility	4.60% 4.98%	Perf 5Y	-61.69%
Dividend TTM	-	EV/Sales	1.41	EPS Y/Y TTM	80.25%	Oper. Margin	-9.80%	ATR (14)	0.61	Perf 10Y	-68.18%
Dividend Ex-Date	-	Quick Ratio	3.86	Sales Y/Y TTM	-25.68%	Profit Margin	-9.64%	RSI (14)	71.44	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	4.72	EPS Q/Q	101.33%	SMA20	10.91%	Beta	0.29	Target Price	17.00
Payout	-	Debt/Eq	0.18	Sales Q/Q	0.04%	SMA50	30.05%	Rel Volume	0.60	Prev Close	14.30
Employees	235	LT Debt/Eq	0.17	Earnings	Feb 26 BMO	SMA200	40.80%	Avg Volume	154.02K	Price	14.20
IPO	May 03, 1993	Option/Short	Yes / Yes	EPS/Sales Surpr.	348.00% 6.03%	Trades		Volume	92,938	Change	-0.70%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-17-25	Initiated	B. Riley Securities	Buy	$21
Nov-01-24	Reiterated	Barrington Research	Outperform	$37 → $25
Aug-14-23	Upgrade	Barrington Research	Mkt Perform → Outperform	$24
Mar-07-23	Downgrade	Barrington Research	Outperform → Mkt Perform
Nov-09-22	Upgrade	Barrington Research	Mkt Perform → Outperform	$31
Oct-14-22	Resumed	Stephens	Equal-Weight	$26
Mar-09-22	Downgrade	Stephens	Overweight → Equal-Weight	$35
Mar-09-22	Downgrade	Barrington Research	Outperform → Mkt Perform
Nov-16-21	Initiated	Stephens	Overweight	$55
Jul-16-21	Initiated	UBS	Neutral	$46
Dec-16-20	Upgrade	Barrington Research	Mkt Perform → Outperform	$43
May-08-20	Downgrade	Barrington Research	Outperform → Mkt Perform
Jan-21-20	Upgrade	Sidoti	Neutral → Buy	$61
Jan-10-20	Upgrade	First Analysis Sec	Outperform → Strong Buy	$65
Nov-05-19	Initiated	BWS Financial	Sell	$29
Sep-24-19	Reiterated	Barrington Research	Outperform	$49 → $58
Sep-23-19	Downgrade	First Analysis Sec	Strong Buy → Outperform	$54
Jul-25-19	Upgrade	First Analysis Sec	Neutral → Strong Buy	$37 → $54
Feb-22-19	Downgrade	Sidoti	Buy → Neutral	$56 → $41
Feb-22-19	Downgrade	First Analysis Sec	Outperform → Neutral	$41 → $37

Show Previous Ratings

Mar-03-26 03:29AM	Anika Therapeutics Touts $3B TAM, Cingal & Hyalofast Growth Plans at Canaccord MSK Conference (MarketBeat)
Feb-26-26 04:09PM	Anika Therapeutics Inc (ANIK) Q4 2025 Earnings Call Highlights: Strong International Growth and ... (GuruFocus.com) +16.91% +12.28%
12:15PM	Anika Therapeutics (ANIK) Q4 Earnings and Revenues Beat Estimates (Zacks)
10:59AM	Anika Therapeutics Q4 Earnings Call Highlights (MarketBeat)
07:35AM	Anika: Q4 Earnings Snapshot (Associated Press Finance)
07:05AM	Loading…
07:05AM	Anika Reports Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
Feb-18-26 04:01PM	Anika To Present at the Canaccord Genuity 2026 Musculoskeletal Conference (GlobeNewswire)
Feb-12-26 04:01PM	Anika to Issue Fourth Quarter and Year-End 2025 Financial Results on Thursday, February 26, 2026 (GlobeNewswire)
Jan-08-26 07:00AM	Anika Therapeutics Announces Leadership Transition (GlobeNewswire)
Nov-06-25 06:00PM	Anika Therapeutics Inc (ANIK) Q3 2025 Earnings Call Highlights: Strong Growth in Regenerative ... (GuruFocus.com)
Nov-05-25 08:25AM	Anika Therapeutics (ANIK) Q3 Earnings and Revenues Top Estimates (Zacks)
07:22AM	Anika: Q3 Earnings Snapshot (Associated Press Finance)
07:05AM	Anika Reports Third Quarter 2025 Financial Results (GlobeNewswire)
07:00AM	Anika Therapeutics Reports Filing of Final PMA Module for Hyalofast Cartilage Repair Scaffold and Data from U.S. Pivotal FastTRACK Phase III Study (GlobeNewswire)
Nov-04-25 08:43AM	Anika Therapeutics Inc (ANIK) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
04:01PM	Loading…
Oct-23-25 04:01PM	Anika to Issue Third Quarter 2025 Financial Results on Wednesday, November 5, 2025 (GlobeNewswire)
Sep-19-25 06:50AM	Arcturus Therapeutics (ARCT) Surges 8.7%: Is This an Indication of Further Gains? (Zacks)
Sep-05-25 05:00AM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Aug-29-25 09:55AM	Wall Street Analysts See a 98.59% Upside in Anika (ANIK): Can the Stock Really Move This High? (Zacks)
Aug-20-25 12:00PM	Anika (ANIK) Upgraded to Buy: Here's What You Should Know (Zacks)
Jul-30-25 08:15AM	Anika Therapeutics (ANIK) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -27.42%
07:21AM	Anika: Q2 Earnings Snapshot (Associated Press Finance)
07:05AM	Anika Reports Second Quarter 2025 Financial Results (GlobeNewswire)
07:00AM	Anika Reports Topline Results from U.S. Pivotal FastTRACK Phase III Study for Hyalofast Cartilage Repair Scaffold and Provides Program Update (GlobeNewswire)
Jul-29-25 10:04AM	Anika Therapeutics Inc (ANIK) Q2 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
08:15AM	uniQure (QURE) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
Jul-21-25 10:11AM	Recursion Pharmaceuticals (RXRX) Soars 5.8%: Is Further Upside Left in the Stock? (Zacks)
Jul-16-25 04:01PM	Anika to Issue Second Quarter 2025 Financial Results on Wednesday, July 30, 2025 (GlobeNewswire)
Jul-03-25 05:00PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jun-05-25 05:00PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
08:00AM	Loading…
May-20-25 08:00AM	Sidoti Events, LLC's Virtual May Micro-Cap Conference (ACCESSWIRE)
May-12-25 05:00PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
09:29AM	Company News for May 12, 2025 (Zacks)
May-10-25 03:04AM	Anika Therapeutics Inc (ANIK) Q1 2025 Earnings Call Highlights: Strategic Growth Amidst Revenue ... (GuruFocus.com)
May-09-25 08:35AM	Anika Therapeutics (ANIK) Reports Q1 Loss, Misses Revenue Estimates (Zacks) -21.03%
07:44AM	Anika Therapeutics Posts Wider Loss From Cont. Ops. In Q1 (RTT News)
07:28AM	Anika: Q1 Earnings Snapshot (Associated Press Finance)
07:05AM	Anika Reports First Quarter 2025 Financial Results (GlobeNewswire)
May-08-25 09:45AM	Earnings To Watch: Anika Therapeutics Inc (ANIK) Reports Q1 2025 Result (GuruFocus.com)
09:05AM	Vericel Corporation (VCEL) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
May-07-25 04:01PM	Anika to Participate in the Sidoti Virtual Investor Conference (GlobeNewswire)
May-05-25 09:28AM	Is the Options Market Predicting a Spike in Anika Therapeutics Stock? (Zacks)
Apr-25-25 09:00AM	Anika to Issue First Quarter 2025 Financial Results on Friday, May 9, 2025 (GlobeNewswire)
Apr-07-25 05:00PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -5.60%
Apr-03-25 08:44AM	Are Options Traders Betting on a Big Move in Anika Therapeutics (ANIK) Stock? (Zacks)
Mar-13-25 06:43AM	Q4 2024 Anika Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents) -11.10%
03:09AM	Anika Therapeutics Inc (ANIK) Q4 2024 Earnings Call Highlights: Navigating Growth and Challenges (GuruFocus.com)
Mar-12-25 05:25PM	Anika Therapeutics (ANIK) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:33PM	Anika: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Anika Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Mar-07-25 06:00AM	Anika Completes Divestiture of Parcus Medical (GlobeNewswire)
Mar-01-25 06:42AM	Is Anika Therapeutics, Inc. (ANIK) the Best Small Cap Pharma Stocks to Buy Now? (Insider Monkey)
Feb-26-25 08:00AM	Anika to Issue Fourth Quarter and Year-End 2024 Financial Results on Wednesday, March 12, 2025 (GlobeNewswire)
Feb-25-25 08:00AM	Anika To Present at the Canaccord Genuity 2025 Musculoskeletal Conference (GlobeNewswire)
Dec-23-24 04:01PM	Anika To Participate in 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-03-24 08:30AM	Sidoti Events, LLC's Virtual December Small-Cap Conference (ACCESS Newswire)
Nov-22-24 04:16PM	Anika To Participate in December 2024 Investor Conferences (GlobeNewswire)
Nov-01-24 03:07AM	Anika Therapeutics Inc (ANIK) Q3 2024 Earnings Call Highlights: Strategic Shifts Amid Revenue ... (GuruFocus.com)
Oct-31-24 11:00AM	Arthrosurface Returns to it Roots Following Divestiture from Anika Therapeutics (PR Newswire) -30.67%
08:25AM	Anika Therapeutics (ANIK) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
07:18AM	Anika: Q3 Earnings Snapshot (Associated Press Finance)
07:05AM	Anika Reports Third Quarter 2024 Financial Results (GlobeNewswire)
07:00AM	Anika Announces Strategic Update of Business with Sale of Arthrosurface and Plan to Divest Parcus Medical (GlobeNewswire)
Oct-30-24 09:19AM	Anika Therapeutics Inc (ANIK) Q3 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Oct-17-24 04:01PM	Anika Announces Third Quarter 2024 Results Conference Call Date (GlobeNewswire)
Oct-09-24 06:04PM	Anika Therapeutics Inc (ANIK) Q2 2024 Earnings Call Highlights: Navigating Revenue Challenges ... (GuruFocus.com)
Oct-04-24 04:01PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Sep-09-24 04:45PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Aug-15-24 04:01PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Aug-09-24 07:41AM	Anika Therapeutics, Inc. (ANIK): Are Hedge Funds Bullish on This Caligan Partners-Approved Stock? (Insider Monkey)
Aug-08-24 06:35PM	Anika Therapeutics (ANIK) Q2 Earnings Lag Estimates (Zacks)
05:27PM	Anika: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Anika Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Aug-05-24 04:01PM	Anika to Participate in the Sidoti Virtual Investor Conference (GlobeNewswire)
Jul-25-24 09:00AM	Anika to Issue Second Quarter 2024 Financial Results on Thursday, August 8, 2024 (GlobeNewswire)
Jul-16-24 07:19AM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jul-11-24 08:30AM	Anika Announces Full Market Release of the Integrity Implant System, a Regenerative Hyaluronic Acid-Based Scaffold for Rotator Cuff and Other Tendon Repairs (GlobeNewswire)
Jul-01-24 10:35AM	Orthopedic Regenerative Surgical Products Market Size to Reach USD 6.6 Billion By 2033, at 4.4 CAGR: Insights by Dimension Market Research (GlobeNewswire)
Jun-07-24 04:01PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
May-28-24 04:05PM	Anika Enters into Cooperation Agreement with Caligan Partners (GlobeNewswire)
May-09-24 12:22PM	Anika Therapeutics, Inc. (NASDAQ:ANIK) Q1 2024 Earnings Call Transcript (Insider Monkey) -11.28%
10:59AM	Q1 2024 Anika Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
04:07AM	Anika Therapeutics Inc (ANIK) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and ... (GuruFocus.com)
May-08-24 08:57PM	ANIK Stock Earnings: Anika Therapeutics Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
05:40PM	Anika: Q1 Earnings Snapshot (Associated Press Finance)
04:08PM	Anika Announces CFO Transition (GlobeNewswire)
04:05PM	Anika Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-03-24 04:01PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Apr-18-24 04:01PM	Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024 (GlobeNewswire)
Apr-02-24 08:00AM	Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-16-24 03:15PM	Anika Therapeutics, Inc. (NASDAQ:ANIK) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-14-24 08:18AM	Q4 2023 Anika Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-13-24 04:47PM	Anika: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Anika Reports Fourth Quarter and Year-End 2023 Financial Results (GlobeNewswire)
Mar-08-24 04:01PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Feb-27-24 04:01PM	Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024 (GlobeNewswire)
Feb-13-24 09:00AM	Anika Highlights Its Recently Launched Integrity Implant System and RevoMotion Reverse Shoulder Arthroplasty System Along with Other Key Regenerative Products During the 2024 AAOS Annual Meeting (GlobeNewswire)
Nov-28-23 09:00AM	Anika Announces First Surgeries Performed using the Integrity Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Rotator Cuff Repairs, Commencing Limited Market Release (GlobeNewswire)
Nov-07-23 04:05PM	Anika to Participate in Upcoming Investor Conferences (GlobeNewswire)
Nov-05-23 02:26PM	Anika Therapeutics, Inc. (NASDAQ:ANIK) Q3 2023 Earnings Call Transcript (Insider Monkey)

Anika Therapeutics, Inc. is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical, ophthalmic and veterinary. The company's main focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management, Regenerative Solutions, Sports Medicine and Arthrosurface Joint Solutions, and its products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika Therapeutics was founded in 1992 and is headquartered in Bedford, MA.

Insider Trading	Relationship	Date	Transaction	#Shares	#Shares Total	SEC Form 4
Griffin Stephen D.	EVP, CFO & COO	Jun 03 '25	Option Exercise	12,840	13,640	Jun 05 05:01 PM
Nunes Anne	SVP, Chief Operations Officer	Mar 17 '25	Option Exercise	3,637	21,722	Mar 18 05:16 PM
Colleran David	EVP, General Counsel, Corp Sec	Mar 17 '25	Option Exercise	6,448	49,847	Mar 18 05:16 PM
Blanchard Cheryl R	President, CEO, Director	Mar 17 '25	Option Exercise	25,132	209,472	Mar 18 05:15 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ANIK

Anika Therapeutics Inc

Upgrade your FINVIZ experience